APA (7th ed.) Citation

Manger, I., Schmitt, C., Berking, C., French, L. E., Vera-Gonzalez, J., & Heinzerling, L. Association of HLA-A*02: 01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study. BMC.

Chicago Style (17th ed.) Citation

Manger, Isabel, Christina Schmitt, Carola Berking, Lars E. French, Julio Vera-Gonzalez, and Lucie Heinzerling. Association of HLA-A*02: 01 Type with Efficacy and Toxicity of Immune Checkpoint Inhibitor Therapy in Melanoma Patients: A Retrospective Cohort Study. BMC.

MLA (9th ed.) Citation

Manger, Isabel, et al. Association of HLA-A*02: 01 Type with Efficacy and Toxicity of Immune Checkpoint Inhibitor Therapy in Melanoma Patients: A Retrospective Cohort Study. BMC.